Here's a look at some of the top regulatory stories for medical device companies this week: New inversion rules unlikely to scuttle Medtronic's $43B Covidien buy; New U.S. tax rules may lead Medtronic to redo inversion deal; Ackman threatens to sue Allergan again over potential Salix deal; Tengion is on the auction block
Medical device and pharmaceutical companies paid out $3.5 billion to doctors and hospitals during the last 5 months of 2013, according to new data from the Centers for Medicare & Medicaid Services, including a $30 million spend by Medtronic.
NEW YORK (Reuters) – U.S. doctors and teaching hospitals received $3.5 billion from medical device makers and pharmaceutical companies in the last 5 months of 2013, according to the most extensive data trove on such payments ever made public.
Here's a look at some of the top legal news stories for medical device companies this week: Boston Scientific loses $309 million judgment in Mirowski patent war; Ex-Advanced Medical Optics CEO Mazzo indicted in insider trading case; Appeals court denies BD bid to revisit loss to Retractable Technologies; Ackman threatens to sue Allergan again over potential Salix deal; Judge upholds $30M infringement ruling against NuVasive, cancels trademark
Abbott Medical Optics
, AcuFocus Inc.
, Advanced Medical Optics
, Becton Dickinson & Co.
, Boston Scientific
, Mirowski Family Ventures
, NeuroVision Medical Products Inc.
, Pershing Square Capital Management
, Retractable Technologies Inc.
, St. Jude Medical
, Valeant Pharmaceuticals
, Versant Ventures
, Allergan Inc.
More and more patients are reportedly hacking into their glucose monitors to add functions like online data display and continuous glucose monitoring.
MASSDEVICE ON CALL — More and more patients are hacking into their glucose monitors to add functionality, with medical device companies lagging behind as they work their own improvements through the FDA, according to the Wall Street Journal.
Medtronic is likely to attempt a renegotiation of its $43 billion acquisition of Covidien now that the U.S. Treasury Dept. has changed the rules on tax inversion deals.
Medtronic pledges a $6 million donation to fight rheumatic fever and the heart damage it can cause.
MASSDEVICE ON CALL — Medtronic (NYSE:MDT) yesterday pledged a $6 million donation to fight rheumatic fever and the heart damage it can cause, as part of a United Nations initiative to improve the health of women and children.
Despite Boston Scientific having yet to debut a pacemaker that nestles inside the heart itself, an analyst said the company may be best positioned to capitalize on sales of such devices.